A unique case of pulmonary minimally invasive mucinous adenocarcinoma arising from atypical goblet cell hyperplasia in the bronchial epithelium of a 9-year-old girl
- PMID: 40296044
- PMCID: PMC12036169
- DOI: 10.1186/s12887-025-05683-9
A unique case of pulmonary minimally invasive mucinous adenocarcinoma arising from atypical goblet cell hyperplasia in the bronchial epithelium of a 9-year-old girl
Abstract
Background: Pulmonary mucinous adenocarcinoma without congenital pulmonary airway malformation (CPAM) is extremely rare in pediatric patients. Here, we report a unique case of minimally invasive mucinous adenocarcinoma without CPAM in a child and provide a comprehensive review of the clinical, radiographic, and histopathological characteristics of the published literature.
Case presentation: A 9-year-old girl presented with persistent cough and sputum production, raising suspicion of respiratory infection. Chest computed tomography (CT) revealed a solid nodule measuring 1.9 cm × 1.6 cm in the right lower lobe. Prenatal ultrasonography revealed no congenital lung abnormality. The patient subsequently underwent video-assisted thoracoscopic surgery (VATS) without postoperative complications. Histologically, a focal area demonstrated marked atypical goblet cell hyperplasia in the bronchial epithelium, which abruptly transitioned to mucinous adenocarcinoma, predominantly characterized by a lepidic growth pattern and extensive extracellular mucin accumulation. Pathological examination confirmed pulmonary minimally invasive mucinous adenocarcinoma, staged as pT1miN0M0. Next-generation sequencing (NGS) identified the KRAS G12D mutation. The patient remained well 11 months after resection and did not require additional treatment.
Conclusions: We demonstrated a novel stepwise progression originating from atypical goblet cell hyperplasia in the bronchial epithelium, rather than from the CPAM, in a pediatric patient. KRAS mutations may play a critical role in the development of pulmonary mucinous adenocarcinoma in pediatric patients.
Keywords: Minimally invasive mucinous adenocarcinoma; Pediatric oncology; Pulmonary adenocarcinoma; VATS.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The respective ethics committee of West China Hospital, Sichuan University, China (No.2020892) granted ethical approval for this retrospective study. Written informed consent was obtained from the parents of the patient. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
References
-
- Neville HL, Hogan AR, Zhuge Y, Perez EA, Cheung MC, Koniaris LG, Thompson WR, Sola JE. Incidence and outcomes of malignant pediatric lung neoplasms. J Surg Res. 2009;156(2):224–30. - PubMed
-
- Chang WC, Zhang YZ, Wolf JL, Hermelijn SM, Schnater JM, von der Thusen JH, Rice A, Lantuejoul S, Mastroianni B, Farver C, et al. Mucinous adenocarcinoma arising in congenital pulmonary airway malformation: clinicopathological analysis of 37 cases. Histopathology. 2021;78(3):434–44. - PubMed
-
- Fakler F, Aykutlu U, Brcic L, Eidenhammer S, Thueringer A, Kashofer K, Kulka J, Timens W, Popper H. Atypical goblet cell hyperplasia occurs in CPAM 1, 2, and 3, and is a probable precursor lesion for childhood adenocarcinoma. Virchows Arch. 2020;476(6):843–54. - PubMed
-
- Lantuejoul S, Nicholson AG, Sartori G, Piolat C, Danel C, Brabencova E, Goldstraw P, Brambilla E, Rossi G. Mucinous cells in type 1 pulmonary congenital cystic adenomatoid malformation as mucinous Bronchioloalveolar carcinoma precursors. Am J Surg Pathol. 2007;31(6):961–9. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
